|
|
Article: Lung Cancer Vaccine to Be Evaluated at Siteman Cancer Center
- Article from:
- Targeted News Service
- Article date:
- December 9, 2008
CopyrightCopyright © HT Media Ltd. All Rights Reserved. Provided by ProQuest LLC. (Hide copyright information)
|
The Washington University St. Louis Medical School issued the following news release:
A vaccine designed to prevent the recurrence of lung cancer is now being tested in centers around the world including the Siteman Cancer Center at Washington University School of Medicine in St. Louis and Barnes-Jewish Hospital.
The vaccine stimulates the immune system to destroy cells that carry a tumor-specific antigen called MAGE-A3. This antigen is not present in normal tissue but is found in several cancer types, including 35 percent to 50 percent of cases of the most common type of lung cancer, non-small cell lung cancer.
The MAGE-A3-based vaccine answers a need for a highly efficient and safe ...